| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| VERA | Vera Therapeutics, Inc. | Chief Development Officer | $485K | Aug 21, 2023 | ||
| VTGN | Vistagen Therapeutics, Inc. | Director | Sep 9, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|